Todd Harris, Chief Executive Officer at Tyra Biosciences, Inc. (TYRA), sold 33,473 shares at $16.00 ($539K) on 2023-06-13, disclosed to the SEC on 2023-06-15.
Scheduled sale ($539k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 7,927 | $127K | 23.5% |
| 2 | $16.13 | 12,773 | $206K | 38.2% |
| 3 | $16.13 | 12,773 | $206K | 38.2% |
| Total | $16.10 avg | 33,473 | $539K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |